Samuelsson J, Mutschler M, Birgegard G, Gram-Hansen P, Bjorkholm M, Pahl H. Limited effects on JAK2 mutational status after pegylated interferon alpha-2b therapy in polycythemia vera and essential thrombocythemia. Haematologica [Internet]. 2006Sep.1 [cited 2026Nov.13];91(9):1281-2. Available from: https://haematologica.org/article/view/4163